Safety and feasibility of coadministration of erlotinib and Theracurmin (nanoparticle curcumin) in patients with advanced or recurrent non-small-cell lung cancer.
Phase of Trial: Phase I
Latest Information Update: 12 May 2016
At a glance
- Drugs Curcumin (Primary) ; Erlotinib
- Indications Non-small cell lung cancer
- Focus Adverse reactions
- 23 Dec 2011 New trial record